Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses

ABSTRACT We have recently demonstrated that CD4+ T cell help is required at the time of adenovirus (Ad) vector immunization for the development of functional CD8+ T cell responses, but the temporal requirement for CD4+ T cell help for the induction of antibody responses remains unclear. Here we demonstrate that induction of antibody responses in C57BL/6 mice can occur at a time displaced from the time of Ad vector immunization by depletion of CD4+ T cells. Transient depletion of CD4+ T cells at the time of immunization delays the development of antigen-specific antibody responses but does not permanently impair their development or induce tolerance against the transgene. Upon CD4+ T cell recovery, transgene-specific serum IgG antibody titers develop and reach a concentration equivalent to that in undepleted control animals. These delayed antibody responses exhibit no functional defects with regard to isotype, functional avidity, expansion after boosting immunization, or the capacity to neutralize a simian immunodeficiency virus (SIV) Env-expressing pseudovirus. The development of this delayed transgene-specific antibody response is temporally linked to the expansion of de novo antigen-specific CD4+ T cell responses, which develop after transient depletion of CD4+ T cells. These data demonstrate that functional vaccine-elicited antibody responses can be induced even if CD4+ T cell help is provided at a time markedly separated from the time of vaccination. IMPORTANCE CD4+ T cells have a critical role in providing positive help signals to B cells, which promote robust antibody responses. The paradigm is that helper signals must be provided immediately upon antigen exposure, and their absence results in tolerance against the antigen. Here we demonstrate that, in contrast to the current model that the absence of CD4+ T cell help at priming results in long-term antibody nonresponsiveness, antibody responses can be induced by adenovirus vector immunization or alum-adjuvanted protein immunization even if CD4+ T cell help is not provided until >1 month after immunization. These data demonstrate that the time when CD4+ T cell help signals must be provided is more dynamic and flexible than previously appreciated. These data suggest that augmentation of CD4+ T cell helper function even after the time of vaccination can enhance vaccine-elicited antibody responses and thereby potentially enhance the immunogenicity of vaccines in immunocompromised individuals.

[1]  A. Brzozowski,et al.  Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies , 2015, PloS one.

[2]  John P. Moore,et al.  Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity , 2015, Journal of Virology.

[3]  H. Schuitemaker,et al.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys , 2015, Science.

[4]  Hongmei Gao,et al.  Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. , 2014, Journal of immunological methods.

[5]  D. Kaufman,et al.  Longitudinal Requirement for CD4+ T Cell Help for Adenovirus Vector–Elicited CD8+ T Cell Responses , 2014, The Journal of Immunology.

[6]  D. Bhattacharya,et al.  Adjuvant-specific regulation of long-term antibody responses by ZBTB20 , 2014, The Journal of experimental medicine.

[7]  P. McKay,et al.  Enhanced Immunogenicity of an HIV-1 DNA Vaccine Delivered with Electroporation via Combined Intramuscular and Intradermal Routes , 2014, Journal of Virology.

[8]  Jerome H. Kim,et al.  Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys , 2013, Cell.

[9]  J. Hamid,et al.  A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity , 2013, Science Translational Medicine.

[10]  S. Targ,et al.  T Follicular Helper Cell Dynamics in Germinal Centers , 2013, Science.

[11]  D. Barouch,et al.  Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors , 2012, Journal of Virology.

[12]  T. Strutt,et al.  Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.

[13]  A. Folgori,et al.  Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man , 2012, Science Translational Medicine.

[14]  Sang-Jun Ha,et al.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection , 2011, Proceedings of the National Academy of Sciences.

[15]  Jerome H. Kim,et al.  Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys , 2011, Nature.

[16]  Mario Roederer,et al.  CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates , 2011, Nature Medicine.

[17]  A. Davidoff,et al.  Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine , 2011, Gene Therapy.

[18]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[19]  Judith Nedrow Production JOURNAL OF VIROLOGY , 2011, Journal of Virology.

[20]  M. Roederer,et al.  IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform , 2010, The Journal of experimental medicine.

[21]  D. Kaufman,et al.  Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8+ T Lymphocytes , 2010, Journal of Virology.

[22]  Holly Janes,et al.  Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.

[23]  Burton E. Barnett,et al.  Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell Differentiation , 2009, Science.

[24]  D. Montefiori,et al.  Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys , 2008, Nature.

[25]  T. Nakayama,et al.  Development and characterization of IL-21–producing CD4+ T cells , 2008, The Journal of experimental medicine.

[26]  K. Mansfield,et al.  Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D , 2007, Journal of Virology.

[27]  J. Bramson,et al.  The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity1 , 2006, The Journal of Immunology.

[28]  S. Kostense,et al.  Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1 , 2004, The Journal of Immunology.

[29]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[30]  J. Cyster,et al.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position , 2002, Nature.

[31]  J. McCluskey,et al.  Cognate T Cell Help Is Sufficient to Trigger Anti-Nuclear Autoantibodies in Naive Mice1 , 2001, The Journal of Immunology.

[32]  S. Harrison,et al.  Expression, Purification, and Characterization of gp160e, the Soluble, Trimeric Ectodomain of the Simian Immunodeficiency Virus Envelope Glycoprotein, gp160* , 2000, The Journal of Biological Chemistry.

[33]  Scott R. Presnell,et al.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.

[34]  E. Ingulli,et al.  Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.

[35]  A. B. Lyons,et al.  The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help , 1996, The Journal of experimental medicine.

[36]  B Zheng,et al.  Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. , 1995, Journal of immunology.

[37]  F. Finkelman,et al.  Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo , 1995, The Journal of experimental medicine.

[38]  R. Zinkernagel,et al.  T helper cell unresponsiveness: Rapid induction in antigen‐transgenic and reversion in non‐transgenic mice , 1994, European journal of immunology.

[39]  R. Zinkernagel,et al.  Virus or a hapten‐carrier complex can activate autoreactive B cells by providing linked T help , 1994, European journal of immunology.

[40]  M. Cooke,et al.  Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death , 1993, Cell.

[41]  D. Gray,et al.  Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.

[42]  Jun Zhang,et al.  Sites of specific B cell activation in primary and secondary responses to T cell‐dependent and T cell‐independent antigens , 1991, European journal of immunology.

[43]  L. Chieco‐Bianchi,et al.  Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. , 1991, Journal of immunology.

[44]  K. Rajewsky,et al.  Persistence of memory B cells in mice deprived of T cell help. , 1990, International immunology.

[45]  Jeffrey Crosbie,et al.  Induction of self-tolerance in mature peripheral B lymphocytes , 1989, Nature.

[46]  J. Goronzy,et al.  Persistent suppression of virus-specific cytotoxic T cell responses after transient depletion of CD4+ T cells in vivo. , 1989, Journal of Immunology.

[47]  D. Nemazee,et al.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes , 1989, Nature.

[48]  W. Paul,et al.  T help requirements for the generation of an in vivo IgE response: a late acting form of T cell help other than IL-4 is required for IgE but not for IgG1 production. , 1989, Journal of immunology.

[49]  S. Smith‐Gill,et al.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.

[50]  C. Fathman,et al.  Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 , 1986, The Journal of experimental medicine.

[51]  H. Waldmann,et al.  Induction of tolerance by monoclonal antibody therapy , 1986, Nature.

[52]  Samir Guglani Death , 1890, The Lancet.

[53]  D. Calado,et al.  Germinal Centers , 2017, Methods in Molecular Biology.

[54]  Yonghong,et al.  The CD8 T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity , 2005 .